Optiver Holding’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Buy
+2,302
New +$132K ﹤0.01% 974
2026
Q1
Sell
-14,215
Closed -$767K 2352
2025
Q4
$767K Buy
+14,215
New +$684K ﹤0.01% 525
2024
Q3
Sell
-2,283
Closed -$94.8K 956
2024
Q2
$94.8K Buy
+2,283
New +$102K ﹤0.01% 519
2024
Q1
Sell
-157
Closed -$8.06K 680
2023
Q4
$8.06K Buy
+157
New +$8.24K ﹤0.01% 458

Other funds holding BMY

Optiver Holding's BMY Position: Q2 2026 in Review

Optiver Holding opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 2,302 shares worth $133K. The stake represents ﹤0.01% of the portfolio and ranks #974 among its holdings. This is a return to the name: Optiver Holding previously reported a position in BMY as recently as Q4 2025.

Optiver Holding first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $767K in Q4 2025. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Optiver Holding held 2,302 shares of Bristol-Myers Squibb worth $133K as of Q2 2026.
  • Bristol-Myers Squibb was a new Optiver Holding position in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #974 holding.
  • Optiver Holding first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
  • Optiver Holding's Bristol-Myers Squibb position peaked at $767K in Q4 2025.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.